An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US
Clinical trial NCT02783651 · COMPLETED
Trial details
- NCT number
- NCT02783651
- Sponsor
- Amgen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-30
- Primary completion
- 2020-03-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.